Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Human Vaccines & Immunotherapeutics|March 18, 2026
Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network studyMichael Smolinski, Jo Lin Chew, Cora Constantinescu, et al.
Trials|February 18, 2018
7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trialNick Daneman, Asgar H Rishu, Ruxandra Pinto, et al.
Trials|July 9, 2026
Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trialConnor Prosty, Alex Carignan, Adrienne K Chan, et al.
JAMA Network Open|June 29, 2026
Procalcitonin to Guide 7 vs 14 Days of Antibiotics in Bloodstream Infections: A Secondary Analysis of the BALANCE TrialRayoun Ramendra, Julie K Wright, Kevin C Kain, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Vaccine|June 23, 2024
Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network studyTiffany Fitzpatrick, Peter Yamoah, Gina Lacuesta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.
Pageof 5